Comprehensive Metabolic Panel Testing Market to Reach $16.1 billion, Globally, by 2032 at 4.8% CAGR: Allied Market Research

Increase in prevalence of chronic diseases, rise in geriatric population, and advancements in diagnostic technologies drive the growth of the global comprehensive metabolic panel testing market.

PORTLAND, Ore., March 21, 2024 /PRNewswire/ — Allied Market Research published a report, titled, “Comprehensive Metabolic Panel Testing Market by Test Type (Proteins, Electrolytes, Kidney Tests, Liver Tests, and Others), Disease Indication (Kidney Diseases, Liver Diseases, Diabetes and Others), and End User (Hospitals, Diagnostic Laboratories, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032″. According to the report, the global comprehensive metabolic panel testing industry generated $10.1 billion in 2022 and is anticipated to generate $16.1 billion by 2032, witnessing a CAGR of 4.8% from 2023 to 2032.

Request Sample of the Report on Comprehensive Metabolic Panel Testing Market Forecast – https://www.alliedmarketresearch.com/request-sample/A269963

Prime determinants of growth

Rise in prevalence of chronic diseases such as chronic kidney diseases, and diabetes, surge in geriatric population, and increase in advancements in diagnostic technologies are the factors that drive the growth of the global comprehensive metabolic panel testing market. However, lack of awareness about CMP testing in underdeveloped regions restricts market growth. Moreover, the high growth potential in emerging countries and rise in surge in trend towards point-of-care testing presents new opportunities in the coming years.

Report coverage & details

Report Coverage	Details
Forecast Period	2023–2032
Base Year	2022
Market Size In 2022	$10.1 Billion
Market Size In 2032	$16.1 Billion
CAGR	4.8 %
No. Of Pages In Report	266
Segments Covered	Test Type, Disease Indication, End User, and Region
Drivers	Rise In Prevalence of Chronic Diseases
	Surge In Geriatric Population
	Advancements In Diagnostic Technologies
Opportunities	High Growth Potential in Emerging Countries
	Surge In Trend Towards Point-Of-Care Testing
Restraints	Lack Of Awareness About Benefits of Comprehensive Metabolic Panel Testing

Recession Impact

During a recession, individuals and governments might tighten their budgets, leading to reduced healthcare spending. This could affect patients’ ability to access and afford comprehensive metabolic panel testing, potentially leading to decreased demand for comprehensive metabolic panel testing products.
However, the surge in prevalence of chronic diseases and rise in technological advancements. This could boost the need for comprehensive metabolic panel testing that is experiencing a moderately positive impact from the global recession.

Want to Explore More, Connect to our Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/A269963

The kidney tests segment to maintain its leadership status throughout the forecast period

By test type, the kidney tests segment held the largest market share in 2022, accounting for more than one-fourth of the global comprehensive metabolic panel testing market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to kidney diseases such as chronic kidney disease (CKD) which have become more prevalent due to factors such as aging populations, diabetes, and hypertension thereby drives the demand for CMP testing.

However, the others segment is expected to register the highest CAGR of 5.8% during the forecast period. This is attributed to the growing awareness of the importance of diabetes management and routine health check-ups and increase in prevalence of diabetes.

The kidney diseases segment to maintain its leadership status throughout the forecast period

By disease indication, the kidney diseases segment held the largest market share in 2022, accounting for more than one-third of the global comprehensive metabolic panel testing market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to emphasis on early detection and proactive management of kidney diseases fuels the demand for routine monitoring through CMP testing.

However, the diabetes segment is expected to register the highest CAGR of 5.7% during the forecast period. This is attributed to heightened awareness and education regarding diabetes and its associated risks that contribute to increased demand for routine metabolic assessments, including glucose monitoring.

The diagnostic laboratories segment to maintain its lead position during the forecast period

By end user, the diagnostic laboratories segment accounted for the largest share in 2022, contributing to nearly half of global comprehensive metabolic panel testing market revenue, and is projected to maintain its lead position during the forecast period. This is attributed to their advanced infrastructure, comprehensive testing capabilities, trained personnel, accessibility, high throughput, integration into healthcare networks, technological advancements, and patient-focused services.

However, the others segment is expected to register the highest CAGR of 5.5% during the forecast period. This is attributed to the rise in demand for convenience, immediate results, accessibility in various healthcare settings, technological advancements in point-of-care devices, decentralized healthcare services.

For Procurement Information- https://www.alliedmarketresearch.com/purchase-enquiry/A269963

North America to maintain its dominance by 2032

By region, North America held the largest market share in terms of revenue in 2022, accounting for more than two-fifths of the global comprehensive metabolic panel testing market revenue and is likely to dominate the market during the forecast period. This is attributed to its well-developed healthcare infrastructure, technological advancements in testing methodologies, and growing emphasis on preventive healthcare practices in North America.

However, the Asia-Pacific region is expected to witness the fastest CAGR of 5.9% from 2023 to 2032. This is attributed to rise in the prevalence of chronic diseases, including diabetes, cardiovascular disorders, and obesity, increase in awareness of the importance of routine health check-ups and preventive healthcare practices is driving the demand for diagnostic services,

Leading Market Players:

Quest Diagnostics
Laboratory Corporation of America Holdings
F. Hoffmann-La Roche Ltd.
Blueprint Genetics
ARUP Laboratories,
Walk-In Lab, LLC.
Applied InGENuity Diagnostics
Scion Lab Services, LLC
Baptist Health
My Care Labs

The report provides a detailed analysis of these key players in the global comprehensive metabolic panel testing market. These players have adopted strategies such as acquisition, product approval and product launch to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to highlight the competitive scenario.

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact

David Correa

1209 Orange Street,

Corporation Trust Center,

Wilmington, New Castle,

Delaware 19801 USA.

Toll Free: +1-800-792-5285

Int’l: +1-503-894-6022

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1-855-550-5975

[email protected]

Web: https://www.alliedmarketresearch.com

Follow Us on: LinkedIn Twitter